Search Results
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea
Search for other papers by Kyungmin Lee in
Google Scholar
PubMed
Search for other papers by Sang-Hyun Lee in
Google Scholar
PubMed
Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science & Technology, Daejeon, Republic of Korea
Search for other papers by Wooil Kim in
Google Scholar
PubMed
Search for other papers by Jangwook Lee in
Google Scholar
PubMed
Search for other papers by Jong-Gil Park in
Google Scholar
PubMed
Search for other papers by Jang-Seong Kim in
Google Scholar
PubMed
Search for other papers by Jung Tae Kim in
Google Scholar
PubMed
Search for other papers by Yea Eun Kang in
Google Scholar
PubMed
Search for other papers by Minho Shong in
Google Scholar
PubMed
Search for other papers by Hyo Jin Lee in
Google Scholar
PubMed
Search for other papers by Jin-Man Kim in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
Daejeon Endo Internal Medicine, Daejeon, Republic of Korea
Search for other papers by Koon Soon Kim in
Google Scholar
PubMed
Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science & Technology, Daejeon, Republic of Korea
Search for other papers by Jeong-Ki Min in
Google Scholar
PubMed
potential of tyrosine kinase inhibitors in the treatment of ATC with low Dsg2 expression levels by targeting hepatocyte growth factor receptor (HGFR, c-MET). Materials and methods Patients and tissue specimens We retrospectively selected 10 ATC
Search for other papers by Gina Chia-Yi Chu in
Google Scholar
PubMed
Search for other papers by Haiyen E Zhau in
Google Scholar
PubMed
Search for other papers by Ruoxiang Wang in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by André Rogatko in
Google Scholar
PubMed
Search for other papers by Xu Feng in
Google Scholar
PubMed
Search for other papers by Majd Zayzafoon in
Google Scholar
PubMed
Search for other papers by Youhua Liu in
Google Scholar
PubMed
Search for other papers by Mary C Farach-Carson in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by Sungyong You in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by Jayoung Kim in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by Michael R Freeman in
Google Scholar
PubMed
Uro-Oncology Research, Surgery, Biomedical Sciences, Biostatistics and Bioinformatics Center, Department of Pathology, Department of Pathology, Department of Biochemistry and Cell Biology, Department of Medicine, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, 8750 Beverly Blvd., Atrium 103, Los Angeles, California 90048, USA Departments of
Search for other papers by Leland W K Chung in
Google Scholar
PubMed
bone and soft tissue homing ( Josson et al . 2011 ). These findings support an important role for RANKL–RANK signaling in PCa metastasis. Hepatocyte growth factor (HGF) and its receptor tyrosine kinase c-Met mediate cell motility, migration, increased
Search for other papers by Stephen Hiscox in
Google Scholar
PubMed
Search for other papers by Nicola J Jordan in
Google Scholar
PubMed
Search for other papers by Wen Jiang in
Google Scholar
PubMed
Search for other papers by Maureen Harper in
Google Scholar
PubMed
Search for other papers by Richard McClelland in
Google Scholar
PubMed
Search for other papers by Chris Smith in
Google Scholar
PubMed
Search for other papers by Robert I Nicholson in
Google Scholar
PubMed
/SF) is a multifunctional cytokine produced by stromal cells and exerts its effects in a paracrine fashion, through activation of the c-Met receptor protein, which is frequently expressed on the cells of epithelial origin ( Comoglio & Trusolino 2002
Search for other papers by Ralph Blumhardt in
Google Scholar
PubMed
University of Texas Health Science Center at San Antonio, San Antonio Military Medical Center, Tennessee Valley VA Healthcare System, Vanderbilt University Medical Center, UAMS Thyroid Center, San Antonio, Texas, USA
Search for other papers by Ely A Wolin in
Google Scholar
PubMed
Search for other papers by William T Phillips in
Google Scholar
PubMed
Search for other papers by Umber A Salman in
Google Scholar
PubMed
University of Texas Health Science Center at San Antonio, San Antonio Military Medical Center, Tennessee Valley VA Healthcare System, Vanderbilt University Medical Center, UAMS Thyroid Center, San Antonio, Texas, USA
Search for other papers by Ronald C Walker in
Google Scholar
PubMed
Search for other papers by Brendan C Stack Jr in
Google Scholar
PubMed
Search for other papers by Darlene Metter in
Google Scholar
PubMed
differentiated thyroid carcinoma . Annals of Otology, Rhinology, and Laryngology 115 607 – 610 . ( doi:10.1177/000348940611500806 ). Bohuslavizki KH Brenner W Lassmann S Tinnemeyer S Tonshoff G Sippel C
Search for other papers by Anne E Cust in
Google Scholar
PubMed
Search for other papers by Rudolf Kaaks in
Google Scholar
PubMed
Search for other papers by Christine Friedenreich in
Google Scholar
PubMed
Search for other papers by Fabrice Bonnet in
Google Scholar
PubMed
Search for other papers by Martine Laville in
Google Scholar
PubMed
Search for other papers by Anne Tjønneland in
Google Scholar
PubMed
Search for other papers by Anja Olsen in
Google Scholar
PubMed
Search for other papers by Kim Overvad in
Google Scholar
PubMed
Search for other papers by Marianne Uhre Jakobsen in
Google Scholar
PubMed
Search for other papers by Véronique Chajès in
Google Scholar
PubMed
Search for other papers by Françoise Clavel-Chapelon in
Google Scholar
PubMed
Search for other papers by Marie-Christine Boutron-Ruault in
Google Scholar
PubMed
Search for other papers by Jakob Linseisen in
Google Scholar
PubMed
Search for other papers by Annekatrin Lukanova in
Google Scholar
PubMed
Search for other papers by Heiner Boeing in
Google Scholar
PubMed
Search for other papers by Tobias Pischon in
Google Scholar
PubMed
Search for other papers by Antonia Trichopoulou in
Google Scholar
PubMed
Search for other papers by Bamia Christina in
Google Scholar
PubMed
Search for other papers by Dimitrios Trichopoulos in
Google Scholar
PubMed
Search for other papers by Domenico Palli in
Google Scholar
PubMed
Search for other papers by Franco Berrino in
Google Scholar
PubMed
Search for other papers by Salvatore Panico in
Google Scholar
PubMed
Search for other papers by Rosario Tumino in
Google Scholar
PubMed
Search for other papers by Carlotta Sacerdote in
Google Scholar
PubMed
Search for other papers by Inger Torhild Gram in
Google Scholar
PubMed
Search for other papers by Eiliv Lund in
Google Scholar
PubMed
Search for other papers by J R Quirós in
Google Scholar
PubMed
Search for other papers by Noémie Travier in
Google Scholar
PubMed
Search for other papers by Carmen Martínez-García in
Google Scholar
PubMed
Search for other papers by Nerea Larrañaga in
Google Scholar
PubMed
Search for other papers by María-Dolores Chirlaque in
Google Scholar
PubMed
Search for other papers by Eva Ardanaz in
Google Scholar
PubMed
Search for other papers by Göran Berglund in
Google Scholar
PubMed
Search for other papers by Eva Lundin in
Google Scholar
PubMed
Search for other papers by H Bas Bueno-de-Mesquita in
Google Scholar
PubMed
Search for other papers by Fränzel J B van Duijnhoven in
Google Scholar
PubMed
Search for other papers by Petra H M Peeters in
Google Scholar
PubMed
Search for other papers by Sheila Bingham in
Google Scholar
PubMed
Search for other papers by Kay-Tee Khaw in
Google Scholar
PubMed
Search for other papers by Naomi Allen in
Google Scholar
PubMed
Search for other papers by Tim Key in
Google Scholar
PubMed
Search for other papers by Pietro Ferrari in
Google Scholar
PubMed
Search for other papers by Sabina Rinaldi in
Google Scholar
PubMed
Search for other papers by Nadia Slimani in
Google Scholar
PubMed
Search for other papers by Elio Riboli in
Google Scholar
PubMed
the association between the MetS and endometrial cancer risk. Thus, there were two main objectives of this prospective study: 1) to assess the risk of endometrial cancer in relation to baseline plasma levels of total cholesterol, HDL-C, low
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Pathology Department, Histopathology Core Unit, Endocrinology Division, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Center (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Cristina Rodríguez-Antona in
Google Scholar
PubMed
Search for other papers by Iván Muñoz-Repeto in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Pathology Department, Histopathology Core Unit, Endocrinology Division, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Center (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Lucia Inglada-Pérez in
Google Scholar
PubMed
Search for other papers by Aguirre A de Cubas in
Google Scholar
PubMed
Search for other papers by Veronika Mancikova in
Google Scholar
PubMed
Search for other papers by Marta Cañamero in
Google Scholar
PubMed
Search for other papers by Agnieszka Maliszewska in
Google Scholar
PubMed
Search for other papers by Álvaro Gómez in
Google Scholar
PubMed
Search for other papers by Rocío Letón in
Google Scholar
PubMed
Search for other papers by Luis J Leandro-García in
Google Scholar
PubMed
Search for other papers by Iñaki Comino-Méndez in
Google Scholar
PubMed
Search for other papers by Lara Sanchez in
Google Scholar
PubMed
Search for other papers by Cristina Álvarez-Escolá in
Google Scholar
PubMed
Search for other papers by Javier Aller in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Pathology Department, Histopathology Core Unit, Endocrinology Division, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Center (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Alberto Cascón in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, ISCIII Center for Biomedical Research on Rare Diseases (CIBERER), Pathology Department, Histopathology Core Unit, Endocrinology Division, Endocrinology Service, Human Cancer Genetics Programme, Spanish National Cancer Center (CNIO), Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
(43) 3 (43) 21 (35) 16 (61) a Only primary tumor cases included in the analysis. b A negative expression is indicated by ‘−’. c A positive expression is indicated by ‘+’. Table 3 Protein expression of EGFR, KIT, MET, PDGFRB, VEGF, VEGFR1, VEGFR2, and
Search for other papers by Elke Tatjana Aristizabal Prada in
Google Scholar
PubMed
Search for other papers by Gerald Spöttl in
Google Scholar
PubMed
Search for other papers by Julian Maurer in
Google Scholar
PubMed
Search for other papers by Michael Lauseker in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Heidelberg, Germany
German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Eva Jolanthe Koziolek in
Google Scholar
PubMed
Search for other papers by Jörg Schrader in
Google Scholar
PubMed
Royal Free Hospital ENETS Centre of Excellence, London, UK
Search for other papers by Ashley Grossman in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zurich, Switzerland
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Search for other papers by Christoph Joseph Auernhammer in
Google Scholar
PubMed
Search for other papers by Svenja Nölting in
Google Scholar
PubMed
in both resistant cell lines, compared to the sensitive control cell line ( P < 0.01). Everolimus resistance increased migration potential and baseline c-Met activation The migration assay reflected a significant increase in the
Search for other papers by Hyun-Seuk Moon in
Google Scholar
PubMed
Division of Endocrinology, Section of Endocrinology, Diabetes, and Metabolism, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
Search for other papers by Christos S Mantzoros in
Google Scholar
PubMed
–60% at physiological and high physiological/pharmacological doses, i.e., 1–50 μg/ml Met when compared with control in human LoVo and mouse MCA38 colon cancer cell lines ( Fig. 1 C and D). Figure 1 Interleukin 1β (IL1β) and metformin (Met) regulate cell
Search for other papers by V V Vax in
Google Scholar
PubMed
Search for other papers by M Gueorguiev in
Google Scholar
PubMed
Search for other papers by I I Dedov in
Google Scholar
PubMed
Search for other papers by A B Grossman in
Google Scholar
PubMed
Search for other papers by M Korbonits in
Google Scholar
PubMed
The oncogenes and/or tumour suppressor genes which may be involved in the transformation process for the vast majority of pituitary tumours remain unknown. There is substantial evidence for derangement of cell cycle control in such tumours, but cell cycle protein mutations identified in other human malignancies are restricted to only a very small subset of sporadic pituitary neoplasms. Krüppel-like factors are DNA-binding transcriptional regulators with diverse effects including the upregulation of the cell cycle protein p21(WAF1/CIP1). It has been reported that the Krüppel-like transcription factor 6 (KLF6) gene is mutated in a proportion (15-55%) of human prostate cancers, and more recent data are emerging regarding mutated KLF6 in nasopharyngeal carcinomas, astrocytoid gliomas and colorectal cancer. We therefore speculated that other tumours such as pituitary adenomas might also harbour such mutations that may be involved in the control of cell proliferation in the pituitary. The aim of the current study was thus to analyse the KLF6 gene for mutations in sporadic pituitary tumours. We analysed 60 pituitary adenomas (15 GH-, four ACTH-, two PRL-secreting and 39 non-functioning) with direct sequence analysis of exons 2 and 3 of the KLF6 gene, the region where most of the previously described mutations are located. Three non-functioning pituitary adenomas of the 60 pituitary tumours (5%) had two identical sequence changes in exon 2 (missense mutation Val165Met, 523G-->A and a silent substitution in Ser77Ser codon 261C-->T). Analysis of genomic DNA extracted from peripheral lymphocytes in one patient confirmed these changes to be present in the germline and they therefore probably represent polymorphisms, although we cannot exclude the possibility that these are predisposing germline mutations. We conclude that mutations of the KLF6 gene are unlikely to play an important role in sporadic pituitary tumorigenesis.
Istituto di Endocrinologia e Oncologia Sperimentale, Dipartimento di Biologia e Patologia Cellulare e Molecolare, Dipartimento di Scienze Farmaceutiche, Consiglio Nazionale delle Ricerche, Napoli, Italy
Search for other papers by Chiara Laezza in
Google Scholar
PubMed
Search for other papers by Simona Pisanti in
Google Scholar
PubMed
Search for other papers by Anna Maria Malfitano in
Google Scholar
PubMed
Search for other papers by Maurizio Bifulco in
Google Scholar
PubMed
coated with 50 μg/ml type IV collagen and blocked with 5 mg/ml BSA. Cells (1×10 5 cells) treated for 24 h with Met-F-AEA alone or in combination with toxin B (100 ng/ml) or Y 27632 (10 μM) were added to the upper compartment and incubated (at 37 °C for 4